Author

A. Zhilenkova

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Development and internal validation of a serum biomarker signature for non-small cell lung cancer: an exploratory case–control study

Blood-based biomarkers are increasingly explored for their ability to distinguish non-small cell lung cancer (NSCLC) from non-malignant conditions. Single markers, however, often show limited performance, which has led to growing interest in combining multiple biological features. Aim. To develop a multivariable di...

A. Zhilenkova, P. Shilo, I. Uchendu et al. · Sechenov Medical Journal · 0 citations

Open access Sep 2026

DEVELOPMENT OF A MULTI-BIOMARKER SERUM SIGNATURE FOR BREAST CANCER DETECTION USING ANGIOGENIC, INFLAMMATORY, AND TISSUE REMODELLING BIOMARKERS

Background: Breast cancer grows by forming new blood vessels through a process called angiogenesis. Single blood biomarker often do not detect breast cancer accurately. This study examined a panel of biomarkers linked to angiogenesis, inflammation, and tissue remodeling to identify a reliable blood-based signature for...

Madu Pascal Akaye, Abah Moses Owoicho, A. Zhilenkova et al. · Genetics and Molecular Resea... · 0 citations

Open access Aug 2026

INTEGRATED BIOINFORMATICS ANALYSIS AND DEVELOPMENT OF A MULTI-BIOMARKER WEIGHTED CLINICAL DECISION SCORE FOR BREAST CANCER RISK STRATIFICATION USING ANGIOGENIC AND INFLAMMATORY SIGNATURES

Background: Breast cancer is characterized by complex interactions between angiogenesis, inflammation, and extracellular matrix remodeling. Single biomarkers lack sufficient diagnostic accuracy, necessitating multi marker approaches. Methods: Blood samples from breast cancer patients and healthy controls were analyzed...

Madu Pascal Akaye, Abah Moses Owoicho, A. Zhilenkova et al. · Genetics and Molecular Resea... · 0 citations